Search research articles
Contact Us
Filters
Showing results (41-50 of 69) with videos related to
Page
of 7
Sort By:
Scientific Reports
|
December 2, 2024
miR-449, identified through antiandrogen exposure, mitigates functional biomarkers associated with ovarian cancer risk
Xia Wang, Ho-Hyung Woo, Michelle Wei, et al.
Journal of Cancer
|
September 16, 2010
Ovarian cancer metastatic to the breast presenting as inflammatory breast cancer: a case report and literature review
Rebecca L Klein, Amanda R Brown, Christian M Gomez-Castro, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 11, 2024
Antiandrogen Flutamide-Induced Restoration of miR-449 Expression Mitigates Functional Biomarkers Associated with Ovarian Cancer Risk
Xia Wang, Ho-Hyung Woo, Michele Wei, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 9, 2014
Randomised phase II study of docetaxel plus vandetanib versus docetaxel followed by vandetanib in patients with persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: SWOG S0904
Robert L Coleman, James Moon, Anil K Sood, et al.
Experimental Biology and Medicine (Maywood, N.J.)
|
March 7, 2014
Autocrine inhibition of the c-fms proto-oncogene reduces breast cancer bone metastasis assessed with in vivo dual-modality imaging
Justin J Jeffery, Katie Lux, John S Vogel, et al.
Oncotarget
|
January 30, 2016
Mechanism of progestin resistance in endometrial precancer/cancer through Nrf2-AKR1C1 pathway
Yiying Wang, Yue Wang, Zhenbo Zhang, et al.
Investigational New Drugs
|
May 15, 2012
Investigation of bendamustine HCL in a phase 2 study in women with resistant ovarian cancer
Amanda F Baker, Denise J Roe, Cynthia Laughren, et al.
International Journal of Cancer
|
May 18, 2010
Personal history of breast cancer as a significant risk factor for endometrial serous carcinoma in women aged 55 years old or younger
Sharon X Liang, Micheal Pearl, Shu Liang, et al.
The Journal of Supportive Oncology
|
January 27, 2011
Pilot study of the prospective identification of changes in cognitive function during chemotherapy treatment for advanced ovarian cancer
Lisa M Hess, Setsuko K Chambers, Kenneth Hatch, et al.
Molecular Imaging and Biology
|
November 30, 2016
Clinical Translation of Tumor Acidosis Measurements with AcidoCEST MRI
Kyle M Jones, Edward A Randtke, Eriko S Yoshimaru, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 69) with videos related to
Sort By:
Page
of 7
Scientific Reports
|
December 2, 2024
miR-449, identified through antiandrogen exposure, mitigates functional biomarkers associated with ovarian cancer risk
Xia Wang, Ho-Hyung Woo, Michelle Wei, et al.
Journal of Cancer
|
September 16, 2010
Ovarian cancer metastatic to the breast presenting as inflammatory breast cancer: a case report and literature review
Rebecca L Klein, Amanda R Brown, Christian M Gomez-Castro, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 11, 2024
Antiandrogen Flutamide-Induced Restoration of miR-449 Expression Mitigates Functional Biomarkers Associated with Ovarian Cancer Risk
Xia Wang, Ho-Hyung Woo, Michele Wei, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 9, 2014
Randomised phase II study of docetaxel plus vandetanib versus docetaxel followed by vandetanib in patients with persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: SWOG S0904
Robert L Coleman, James Moon, Anil K Sood, et al.
Experimental Biology and Medicine (Maywood, N.J.)
|
March 7, 2014
Autocrine inhibition of the c-fms proto-oncogene reduces breast cancer bone metastasis assessed with in vivo dual-modality imaging
Justin J Jeffery, Katie Lux, John S Vogel, et al.
Oncotarget
|
January 30, 2016
Mechanism of progestin resistance in endometrial precancer/cancer through Nrf2-AKR1C1 pathway
Yiying Wang, Yue Wang, Zhenbo Zhang, et al.
Investigational New Drugs
|
May 15, 2012
Investigation of bendamustine HCL in a phase 2 study in women with resistant ovarian cancer
Amanda F Baker, Denise J Roe, Cynthia Laughren, et al.
International Journal of Cancer
|
May 18, 2010
Personal history of breast cancer as a significant risk factor for endometrial serous carcinoma in women aged 55 years old or younger
Sharon X Liang, Micheal Pearl, Shu Liang, et al.
The Journal of Supportive Oncology
|
January 27, 2011
Pilot study of the prospective identification of changes in cognitive function during chemotherapy treatment for advanced ovarian cancer
Lisa M Hess, Setsuko K Chambers, Kenneth Hatch, et al.
Molecular Imaging and Biology
|
November 30, 2016
Clinical Translation of Tumor Acidosis Measurements with AcidoCEST MRI
Kyle M Jones, Edward A Randtke, Eriko S Yoshimaru, et al.
Page
of 7